(Q54953776)

English

SK-MEL-113

cell line

SK-Mel-113
SKMEL-113
EL-Mel

In more languages

default for all languages

No label defined

No description defined

Statements

1 reference

Cellosaurus release 49

14 July 2024

cancer cell line

1 reference

Cellosaurus release 49

14 July 2024

described by source

Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity

1 reference

Cellosaurus release 49

14 July 2024

Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma

1 reference

Cellosaurus release 49

14 July 2024

Serological survey of normal humans for natural antibody to cell surface antigens of melanoma

1 reference

Cellosaurus release 49

14 July 2024

Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF

1 reference

Cellosaurus release 49

14 July 2024

Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence

1 reference

Cellosaurus release 49

14 July 2024

HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines

1 reference

Cellosaurus release 49

14 July 2024

Virtually 100% of melanoma cell lines harbor alterations at the DNA level withinCDKN2A, CDKN2B, or one of their downstream targets

1 reference

Cellosaurus release 49

14 July 2024

established from medical condition

1 reference

Cellosaurus release 49

14 July 2024

derived from organism type

1 reference

Cellosaurus release 49

14 July 2024

Identifiers

1 reference

Cellosaurus release 49

14 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54953776&oldid=2258560743"